Health Condition 1: N912- Amenorrhea, unspecified
Conditions
Interventions
Intervention1: Itrifal Khubs-ul-Hadeed and ?abb-e-Mudir: 5mg orally with water after meals at bedtime and 4gm orally with water after meals twice daily respectively for the duration of 5-10 days from
Sponsors
Central Council for Research in Unani Medicine CCRUM New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: 1. Married /unmarried patients in the age group of 18-40 years. 2. Patients with secondary amenorrhoea due to PCOS. 3. Patients willing to take part in the study.
Exclusion criteria
Exclusion criteria: 1. Patients with primary Amenorrhoea and primary ovarian failure 2. Patients with hyperprolactinaemia 3. Patients with any systemic illness and malignancy 4. Pregnant and lactating woman 5. Patients with bleeding disorders 6. Patients taking OCP’s / IUCD
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The efficacy of study drug will be assessed on the basis of observations of clinical findings before and after treatment i.e. Restoration of normal menstruation: 1. Less than 2 days 2. More than 2 days Timepoint: During 1st, 2nd and 3rd menstrual periods. | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological & biochemical assessment for safety assessment i.e. CBC, LFT, KFT, Urine Routine & microscopic examination. Timepoint: At baseline, 2 weeks & at the end of study (3 months) | — |
Countries
India
Contacts
Public ContactDr Pradeep Kumar
Central Council for Research in Unani Medicine (CCRUM)
Outcome results
None listed